Hematopoietic stem cell transplantation for CD3δ deficiency. Read more about Hematopoietic stem cell transplantation for CD3δ deficiency.
Airway microbiota and bronchial hyperresponsiveness in patients with suboptimally controlled asthma. Read more about Airway microbiota and bronchial hyperresponsiveness in patients with suboptimally controlled asthma.
A trial of clarithromycin for the treatment of suboptimally controlled asthma. Read more about A trial of clarithromycin for the treatment of suboptimally controlled asthma.
Accumulation of intraepithelial mast cells with a unique protease phenotype in T(H)2-high asthma. Read more about Accumulation of intraepithelial mast cells with a unique protease phenotype in T(H)2-high asthma.
Mutations in STAT3 and diagnostic guidelines for hyper-IgE syndrome. Read more about Mutations in STAT3 and diagnostic guidelines for hyper-IgE syndrome.
Large deletions and point mutations involving the dedicator of cytokinesis 8 (DOCK8) in the autosomal-recessive form of hyper-IgE syndrome. Read more about Large deletions and point mutations involving the dedicator of cytokinesis 8 (DOCK8) in the autosomal-recessive form of hyper-IgE syndrome.
Improving cellular therapy for primary immune deficiency diseases: recognition, diagnosis, and management. Read more about Improving cellular therapy for primary immune deficiency diseases: recognition, diagnosis, and management.
Management of chronic obstructive pulmonary disease: moving beyond the asthma algorithm. Read more about Management of chronic obstructive pulmonary disease: moving beyond the asthma algorithm.
Murine atopic dermatitis responds to peroxisome proliferator-activated receptors alpha and beta/delta (but not gamma) and liver X receptor activators. Read more about Murine atopic dermatitis responds to peroxisome proliferator-activated receptors alpha and beta/delta (but not gamma) and liver X receptor activators.
